Ramsay Generale de Sante SA (FR:GDS)
:GDS
Want to see FR:GDS full AI Analyst Report?
GDS Stock Chart & Stats
€9.34
€0.00(0.00%)
At close: 4:00 PM EST
€9.34
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€8.72 - €11.25
Previous CloseN/A
Volume15.00
Average Volume (3M)31.35K
Market Cap
€1.09B
Enterprise Value€6.74B
Total Cash (Recent Filing)€218.10M
Total Debt (Recent Filing)€5.86B
Price to Earnings (P/E)―
Beta0.16
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.42
Shares Outstanding110,389,690
10 Day Avg. Volume445
30 Day Avg. Volume31,348
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.06
Price to Sales (P/S)0.23
P/FCF Ratio2.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Free Cash Flow GrowthA 25.21% free cash flow growth and a robust operating cash flow to net income ratio indicate durable internal cash generation. That cash capacity supports working capital, recurring capex for facilities, and reduces near-term reliance on external funding, strengthening medium-term operational flexibility.
Revenue StabilityConsistent, if modest, revenue growth demonstrates stable demand for core healthcare services under France's reimbursement system. Predictable top-line trends allow multi-period planning for staffing, capacity and incremental investments, reducing execution risk over a 2–6 month horizon.
Diversified Services And Scale BenefitsA broad service mix—acute, maternity, emergency, rehabilitation and psychiatry—spreads volume and reimbursement risk across lines. Operating multiple clinics/hospitals creates scale benefits in procurement, staffing and payer contracting, supporting durable margins and resilience to localized demand shifts.
Bears Say
High LeverageSignificant leverage increases fixed financing costs and reduces balance sheet flexibility. With elevated debt levels, the company faces greater refinancing and interest-rate exposure, limiting capacity to absorb reimbursement pressure or fund strategic initiatives without raising additional capital or cutting investment.
Negative Profitability / ROENegative net margins and ROE point to structural shortfalls after operating and financing costs. Persistent unprofitability impairs retained earnings, constrains reinvestment, and raises the bar for operational improvements or cost restructuring needed to restore sustainable shareholder returns.
Cash Flow Vs. Accounting Earnings MismatchA gap between strong free cash flow growth and negative net income suggests non-cash items, timing differences, or substantial financial costs. While cash generation helps near-term liquidity, sustained recovery requires converting cash strength into recurring accounting profitability to lower financing risk.
Ramsay Generale de Sante News
GDS FAQ
What was Ramsay Generale de Sante SA’s price range in the past 12 months?
Ramsay Generale de Sante SA lowest stock price was €8.72 and its highest was €11.25 in the past 12 months.
What is Ramsay Generale de Sante SA’s market cap?
Ramsay Generale de Sante SA’s market cap is €1.09B.
When is Ramsay Generale de Sante SA’s upcoming earnings report date?
Ramsay Generale de Sante SA’s upcoming earnings report date is Aug 20, 2026 which is in 107 days.
How were Ramsay Generale de Sante SA’s earnings last quarter?
Ramsay Generale de Sante SA released its earnings results on Feb 25, 2026. The company reported -€0.316 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.316.
Is Ramsay Generale de Sante SA overvalued?
According to Wall Street analysts Ramsay Generale de Sante SA’s price is currently Overvalued.
Does Ramsay Generale de Sante SA pay dividends?
Ramsay Generale de Sante SA pays a Semiannually dividend of €0.791 which represents an annual dividend yield of N/A. See more information on Ramsay Generale de Sante SA dividends here
What is Ramsay Generale de Sante SA’s EPS estimate?
Ramsay Generale de Sante SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ramsay Generale de Sante SA have?
Ramsay Generale de Sante SA has 110,389,690 shares outstanding.
What happened to Ramsay Generale de Sante SA’s price movement after its last earnings report?
Ramsay Generale de Sante SA reported an EPS of -€0.316 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.926%.
Which hedge fund is a major shareholder of Ramsay Generale de Sante SA?
Currently, no hedge funds are holding shares in FR:GDS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Ramsay Generale de Sante SA
Ramsay Générale de Santé SA operates hospitals in France. Its hospitals offer a range of services in the areas of anesthesia, oncology, cardiology, dermatology, gastroenterology, gynecology, maternity, nephrology, neurosurgery, obesity, ophthalmology, orthopedics, stomatology, pneumonology, psychiatry, radiology, and urology, as well as thoracic, vascular, and endovascular surgeries. The company was formerly known as Générale de Santé SA and changed its name to Ramsay Générale de Santé SA in December 2015. Ramsay Générale de Santé SA was founded in 1987 and is based in Paris, France. Ramsay Générale de Santé SA operates as a subsidiary of Ramsay Health Care Limited.